A
Aralex
Aachen research explorer
Sign in
Menu
Papers
Authors
Topics
Journals
Patents
Institutions
Departments
Sign in
Papers
Authors
Topics
Journals
Patents
Organizations
Institutions
Departments
Unit
Universitätsklinikum Aachen
3Universitätsklinikum Aachen
▲
Sign in to save
2 authors · 2 authorships ·
All papers →
People
2
Search
Sort
Most cited
h-index
Aachen papers
Name
Any field
Agricultural and Biological Sciences
Arts and Humanities
Biochemistry, Genetics and Molecular Biology
Business, Management and Accounting
Chemical Engineering
Chemistry
Computer Science
Decision Sciences
Dentistry
Earth and Planetary Sciences
Economics, Econometrics and Finance
Energy
Engineering
Environmental Science
Health Professions
Immunology and Microbiology
Materials Science
Mathematics
Medicine
Neuroscience
Nursing
Pharmacology, Toxicology and Pharmaceutics
Physics and Astronomy
Psychology
Social Sciences
Veterinary
▲
Steffen Koschmieder
Medicine
11.7k
citations
55
h-index
217
Aachen papers
▲
Martina Margrit Crysandt
Universitätsklinikum Aachen
·
RWTH Aachen University
Medicine
2.35k
citations
22
h-index
96
Aachen papers
2 results
Papers
2
Search
Sort
Most cited
Newest
Oldest
Patent citations
Title
Any type
article
review
book-chapter
conference-paper
preprint
dissertation
book
dataset
other
Any field
Agricultural and Biological Sciences
Arts and Humanities
Biochemistry, Genetics and Molecular Biology
Business, Management and Accounting
Chemical Engineering
Chemistry
Computer Science
Decision Sciences
Dentistry
Earth and Planetary Sciences
Economics, Econometrics and Finance
Energy
Engineering
Environmental Science
Health Professions
Immunology and Microbiology
Materials Science
Mathematics
Medicine
Neuroscience
Nursing
Pharmacology, Toxicology and Pharmaceutics
Physics and Astronomy
Psychology
Social Sciences
Veterinary
Open access
Improved long-term tolerability and efficacy of asciminib-based combination therapies in newly diagnosed CML patients - the fascination trial.
2025
Blood
conference-abstract
Medicine
Chronic Myeloid Leukemia Treatments
Open access
4
citations
Fedratinib in combination with CC-486, an oral hypomethylating agent, in patients with accelerated phase myelofibrosis: Results from the phase I/II famy trial
2025
Blood
conference-abstract
Medicine
Myeloproliferative Neoplasms: Diagnosis and Treatment
Open access
1
citations
2 results